Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The India's drug regulator Drugs Controller General of India (DCGI) has approved Shenzhen Mellow Hope Pharm Industrial's registration of Cerebroprotein Hydrolysate for injection (Cognistar).
Subscribe to our email newsletter
Cognistar is a nutriment for the brain which regulates and improves nerve cell metabolism, promotes synapse generation, induces nerve cell differentiation, and protects nerve cells against damages by ischemia and neurotoxins, Mellow Hope said.
Mellow Hope expects to launch Cognistar in the local market, as soon as the approval is finalised.
The comopany said that until this point there has been no local supplier in India for Cognistar, so the company anticipates healthy sales as it fills this market vacancy and claims a large market share.
Mellow Hope received permit to import Cognistar to India.